About Suzhou Ze Jing Biological Pharmaceutical
Suzhou Ze Jing Biological Pharmaceutical is a company based in Suzhou (China) founded in 2009.. Suzhou Ze Jing Biological Pharmaceutical has raised $61.92 million across 1 funding round from investors including Minsheng Life Insurance, Shenzhen Capital Group and Share Capital. Suzhou Ze Jing Biological Pharmaceutical operates in a competitive market with competitors including Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
- Headquarter Suzhou, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$61.92 M (USD)
in 1 rounds
-
Latest Funding Round
$61.92 M (USD), Series B
Jan 15, 2018
-
Investors
Minsheng Life Insurance
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Suzhou Ze Jing Biological Pharmaceutical
Suzhou Ze Jing Biological Pharmaceutical has successfully raised a total of $61.92M through 1 strategic funding round. The most recent funding activity was a Series B round of $61.92 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $61.9M
-
First Round
First Round
(15 Jan 2018)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Series B - Suzhou Ze Jing Biological Pharmaceutical | Valuation | Minsheng Life Insurance , Shenzhen Capital Group |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Suzhou Ze Jing Biological Pharmaceutical
Suzhou Ze Jing Biological Pharmaceutical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Minsheng Life Insurance, Shenzhen Capital Group and Share Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital, equity investment, and fund management services in China.
|
Founded Year | Domain | Location | |
|
A venture capital firm based in Shenzhen, China, is operated.
|
Founded Year | Domain | Location | |
|
Provider of early stage venture capital focused on technology companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Suzhou Ze Jing Biological Pharmaceutical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Suzhou Ze Jing Biological Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Suzhou Ze Jing Biological Pharmaceutical Comparisons
Competitors of Suzhou Ze Jing Biological Pharmaceutical
Suzhou Ze Jing Biological Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| domain | founded_year | HQ Location |
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Suzhou Ze Jing Biological Pharmaceutical
Frequently Asked Questions about Suzhou Ze Jing Biological Pharmaceutical
When was Suzhou Ze Jing Biological Pharmaceutical founded?
Suzhou Ze Jing Biological Pharmaceutical was founded in 2009 and raised its 1st funding round 9 years after it was founded.
Where is Suzhou Ze Jing Biological Pharmaceutical located?
Suzhou Ze Jing Biological Pharmaceutical is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Is Suzhou Ze Jing Biological Pharmaceutical a funded company?
Suzhou Ze Jing Biological Pharmaceutical is a funded company, having raised a total of $61.92M across 1 funding round to date. The company's 1st funding round was a Series B of $61.92M, raised on Jan 15, 2018.
What does Suzhou Ze Jing Biological Pharmaceutical do?
Founded in 2009 in Suzhou, China, the biopharmaceutical firm focuses on small-molecule and recombinant protein drug development. Operations are divided between subsidiaries in Shanghai for small molecules and Suzhou for protein-based therapies. Key assets include Donafenib in phase III trials for cancer, Jaktinib in phase I for autoimmune diseases and cancer, and rhThrombin in phase I for surgical bleeding, alongside other candidates like ZG0320 and ZG001.
Who are the top competitors of Suzhou Ze Jing Biological Pharmaceutical?
Suzhou Ze Jing Biological Pharmaceutical's top competitors include Merck, Roivant Sciences and Amgen.
Who are Suzhou Ze Jing Biological Pharmaceutical's investors?
Suzhou Ze Jing Biological Pharmaceutical has 5 investors. Key investors include Minsheng Life Insurance, Shenzhen Capital Group, Share Capital, Zhongqing Guorong, and NLVC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.